No Data
No Data
Does Avid Bioservices (CDMO) Have Hidden Potential Despite Current Weakness?
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating
Craig-Hallum analyst Matt Hewitt maintains $Avid Bioservices(CDMO.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 42.7% and a total average return of -4.4% over
Craig-Hallum Reaffirms Their Buy Rating on Avid Bioservices (CDMO)
Avid Bioservices (NASDAQ:CDMO) Is Making Moderate Use Of Debt
KeyBanc Maintains Avid Bioservices(CDMO.US) With Buy Rating, Maintains Target Price $14
KeyBanc analyst Paul Knight maintains $Avid Bioservices(CDMO.US)$ with a buy rating, and maintains the target price at $14.According to TipRanks data, the analyst has a success rate of 42.1% and a tot
Why Avid Bioservices Stock Is Moving Higher Wednesday
No Data